InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Bailey Michael P, 董事长兼首席执行官. Director active across 2 companies, notably Aveo Pharmaceuticals, INC.. Aggregated, 4 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €82k. Activity tracked since 1 September 2021. The latest transaction was filed on 21 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Michael P. Bailey is the Chairman and CEO of AVEO Pharmaceuticals, Inc. He leads the company in the development of innovative treatments for cancer-related diseases. His leadership is crucial in guiding the company's strategy and ensuring its success in the pharmaceutical market.